Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 2002

View Archived Issues

Nascobal approved in Sweden for vitamin B12 malabsorption

Pfizer returns development rights for BioBypass to GenVec

Cell Pathways to distribute Sinclair's Gelclair oral gel in North America

BioSante licenses new hormone replacement product for female sexual dysfunction from Antares

Polyheal 1 enters clinical study for treatment of foot ulcers in diabetic neuropathic patients

Proof of principle demonstrated for steroid-mediated gene delivery

Restructuring announced by Valentis

Naturally occurring angiostatic agents identified by Scripps to have potential in eye diseases

Chemical-genomics collaboration announced by Acadia and Amgen

Cell Pathways updates phase IIa program of CP-461 in cancer

Human Genome Sciences submits IND for B-cell-targeting LymphoRad

Nymox expands Alzheimer's disease research with new agreement

Synagis approved in Japan; receives award in Germany

New antigen targets the focus of an ExonHit/Idec collaboration

Carrington collaborates with SRI on drug delivery technology

Cellegy readying launch of Anogesic

Biovail's extended-release pain medication successfully completes another phase III trial

Novel group of compounds identified as chemokine antagonists

Dihydropyridine-containing calcium channel antagonists from Ortho-McNeil

Celltech discloses potent and selective inhibitors of alpha4 integrins

Cyclohexylamines effective as NMDA receptor antagonists according to recent patents

Piperidine derivatives identified at AstraZeneca as modulators of chemokine receptors

Glutamate receptor-potentiating compounds claimed for use in cognition disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...